EGFR-HER2 inhibitor Mutant EGFR inhibitor, Purity ≥98%

Cat. No.: X24-05-ZQ680

EGFR-HER2 inhibitor Mutant EGFR inhibitor, Purity ≥98%

Synonym: 1421373-62-7; Mutant EGFR inhibitor; CHEMBL3353408; MDK3627; N-[5-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide; EGFR-HER2 inhibitor

  • CAS Number: 1421373-62-7
  • Compound CID: 78357783
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Mutant EGFR inhibitor is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells.
Molecular Weight
520.03
Molecular Formula
C27H30ClN7O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Mutant EGFR inhibitor can be used to explore its therapeutic effects on EGFR-mutated cancers.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.